| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $24.1M | — |
| R&D Expense | $386.0M | +45.4% |
| SG&A Expense | $91.9M | +161.0% |
| Operating Income | -$453.8M | -50.9% |
| Pre-tax Income | -$251.9M | +14.4% |
| Income Tax | -$8.6M | — |
| Net Income | -$243.3M | +17.3% |
| EPS (Basic) | -$2.86 | +72.4% |
| EPS (Diluted) | -$2.86 | +72.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $89.7M | -47.1% |
| Short-term Investments | $218.8M | +84.3% |
| Current Assets | $318.2M | +3.9% |
| Total Assets | $411.9M | +20.8% |
| Current Liabilities | $73.3M | +44.0% |
| Total Liabilities | $110.6M | +36.8% |
| Stockholders' Equity | $301.3M | +15.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$369.5M | -44.9% |
| Capital Expenditures | $653K | -62.3% |
| Investing Cash Flow | $287.9M | +353.0% |
| Financing Cash Flow | $2.1M | -99.6% |
| Free Cash Flow | -$370.2M | -44.1% |